Steffens Julian Miles, Budny Tymoteusz, Gosheger Georg, De Vaal Marieke, Rachbauer Anna Maria, Laufer Andrea, Engel Nina Myline, Deventer Niklas
Department of Orthopedics and Tumororthopedics, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149 Muenster, Germany.
Department of Orthopedics and Trauma, University Hospital Essen, Hufelandstr. 55, 45147 Essen, Germany.
Biomedicines. 2025 Apr 22;13(5):1011. doi: 10.3390/biomedicines13051011.
: The World Health Organization's (WHO) classification of tumors contains around 80 entities of soft tissue sarcomas (STSs). Currently, surgery is the standard treatment for patients with localized STS, but the adequacy of resection margins in soft tissue sarcomas (STSs) remains a topic of intense discussion. : This single-center study retrospectively reviewed 203 patients with primary high-grade soft tissue sarcoma, including a follow-up period of at least 24 months. Patients with prior resection, secondary STS, metastasis at presentation, or those who required amputational surgery were excluded from the study. Patients were categorized based on their margin thickness: positive (n = 13, 6.4%), 0-1 mm (n = 67, 33.0%), 1-5 mm (n = 70, 34.5%), and >5 mm (n = 27, 13.3%). : A total of 64 out of 203 (31.5%) patients developed a local recurrence. The estimated 5-year local-recurrence-free survival (LRFS) was 11.5% (CI 4-25%) for positive margins, 58% (CI 51-64%) for margins 0-1 mm, 76% (CI 70-81%) for margins > 1-5 mm, and 93% (CI 88-98%) for margins > 5 mm. No local recurrences occurred in patients with margins > 5 mm and adjuvant radiotherapy. Margin status significantly influenced the development of distant metastasis and overall survival. Adjuvant radiotherapy improved both local control and overall survival. : To minimize the risk of local recurrence (LR), a resection margin greater than 5 mm should be attained. When adjuvant radiotherapy is applied, the likelihood of LR decreases even more. In scenarios where preserving critical structures is essential, a resection margin of less than 5 mm can be acceptable for ensuring local control.
世界卫生组织(WHO)的肿瘤分类包含约80种软组织肉瘤(STS)实体。目前,手术是局限性STS患者的标准治疗方法,但软组织肉瘤(STS)切除边缘的充分性仍是一个激烈讨论的话题。 本单中心研究回顾性分析了203例原发性高级别软组织肉瘤患者,随访期至少24个月。既往有手术切除史、继发性STS、初诊时伴有转移或需要截肢手术的患者被排除在研究之外。患者根据切缘厚度分类:阳性(n = 13,6.4%)、0 - 1毫米(n = 67,33.0%)、1 - 5毫米(n = 70,34.5%)和>5毫米(n = 27,13.3%)。 203例患者中有64例(31.5%)发生局部复发。切缘阳性患者的5年无局部复发生存率(LRFS)估计为11.5%(CI 4 - 25%),切缘0 - 1毫米患者为58%(CI 51 - 64%),切缘>1 - 5毫米患者为76%(CI 70 - 81%),切缘>5毫米患者为93%(CI 88 - 98%)。切缘>5毫米且接受辅助放疗的患者未发生局部复发。切缘状态显著影响远处转移的发生和总生存期。辅助放疗改善了局部控制和总生存期。 为将局部复发(LR)风险降至最低,应获得大于5毫米的切除边缘。应用辅助放疗时,LR的可能性会进一步降低。在保留关键结构至关重要的情况下,小于5毫米的切除边缘对于确保局部控制可能是可以接受的。